Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03134339Phase 1Completed
Phase 1, randomised, single-blind trial of nicotine in nicotine dependence (4 arms), sponsored by Yale University. Primary endpoint: Peak Change on items of the Drug Effects Questionnaire. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03134339.